AMT vs TRAW · P/E 31, rev $10.64B vs rev $2.8M
American Tower Corp (AMT) versus Traws Pharma Inc (TRAW) — a side-by-side from cached financials, not a winner call.
American Tower Corp (AMT) is a reit - specialty company listed on US.
Traws Pharma Inc (TRAW) is a biotechnology company listed on NASDAQ.
Latest reported AMT revenue for 2025-12-31 was $10.64B. Net income was $2.63B. Revenue was up 317.8% from 2024-12-31 to 2025-12-31. AMT currently screens at market cap $90.44B and trailing P/E 31.4.
Latest reported TRAW revenue for 2025-09-30 was $2.8M. Net income was $16.6M. Revenue was up 2.1% from 2025-06-30 to 2025-09-30. TRAW currently screens at market cap $12.1M.
AMT currently screens at market cap $90.44B and trailing P/E 31.4. TRAW currently screens at market cap $12.1M.
Not investment advice. Open the AMT and TRAW stock pages for the full models.
Not investment advice.